title: Gliomatosis cerebri treatment in 11 elderly patients.
abstract: The Authors report their experience in the treatment of eleven patients over 70 years old (range from 70 to 83, average age 74.8, 7 males and 4 females), with histologically proven diagnosis of glioblastoma multiforme. The GC golden standard treatment is still debated, particularly in elderly patients. All the patients underwent a first line treament with chemotherapy (Temozolomide), followed by Whole Brain Radiotherapy (WBRT) and PCV schedule without Vincristine in case of progression of the disease. The median survival was 16.3 months, ranging from 13 to 22 months. According to our experience, elderly patients should undergo the same treatment of younger patients, provided they are in good health conditions.
authors.affiliation: Department of Neurosurgical Sciences, University of Rome La Sapienza, Rome, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Piccirilli
authors.forename: A
authors.initials: A
authors.lastname: Landi
authors.forename: M
authors.initials: M
authors.lastname: Salvati
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000008:administration & dosage / Q000031:analogs & derivatives; D018450:Disease Progression; D005260:Female; D006801:Humans; D008130:Lomustine / Q000008:administration & dosage; D008279:Magnetic Resonance Imaging; D008297:Male; D018302:Neoplasms, Neuroepithelial / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D011344:Procarbazine / Q000008:administration & dosage; D015996:Survival Rate; D000077204:Temozolomide
chemical_list: D011344:Procarbazine; D008130:Lomustine; D003606:Dacarbazine; D000077204:Temozolomide